SUPREME: A 12-week, open-label, multicenter study to compare the lipid effects of niacin ER [extended release] and simvastatin (NS) to atorvastatin in subjects with hyperlipidemia or mixed dyslipidemia.

Trial Profile

SUPREME: A 12-week, open-label, multicenter study to compare the lipid effects of niacin ER [extended release] and simvastatin (NS) to atorvastatin in subjects with hyperlipidemia or mixed dyslipidemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jun 2011

At a glance

  • Drugs Atorvastatin; Niacin/simvastatin
  • Indications Hyperlipidaemia; Lipid metabolism disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms SUPREME
  • Most Recent Events

    • 20 May 2009 Actual patient number (199) added as reported by ClinicalTrials.gov.
    • 13 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top